Ocugen, Inc

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ocugen, Inc and other ETFs, options, and stocks.

About OCGN

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN.

CEO

Shankar Musunuri

CEOShankar Musunuri

Employees

Employees95

Headquarters

Malvern, Pennsylvania

HeadquartersMalvern, Pennsylvania

Founded

2013

Founded2013

Employees

Employees95

OCGN Key Statistics

Market cap

297.87M

Market cap297.87M

Price-Earnings ratio

-5.27

Price-Earnings ratio-5.27

Dividend yield

—

Dividend yield—

Average volume

10.80M

Average volume10.80M

High today

$1.09

High today$1.09

Low today

$0.98

Low today$0.98

Open price

$1.05

Open price$1.05

Volume

48.31M

Volume48.31M

52 Week high

$1.98

52 Week high$1.98

52 Week low

$0.515

52 Week low$0.515

People also own

Based on the portfolios of people who own OCGN. This list is generated using Robinhood data, and it’s not a recommendation.